RBDCOV_EU (@rbdcov_eu) 's Twitter Profile
RBDCOV_EU

@rbdcov_eu

RBDCOV aims to test the efficacy, tolerability, and safety of two new clinical trials against COVID-19.

Project funded by the @HorizonEU programme.

ID: 1477914864211439617

linkhttps://rbdcov.eu/ calendar_today03-01-2022 08:09:34

496 Tweet

191 Followers

380 Following

RBDCOV_EU (@rbdcov_eu) 's Twitter Profile Photo
RBDCOV_EU
@rbdcov_eu

a month ago

To test how well the #BIMERVAX vaccine works, our partner research laboratories at IDIBAPS and IrsiCaixa have been assessing both the antibody and immune cell responses during the #RBDCOV trials. Have a look at our latest specialised article! 🔴👉shorturl.at/RninO

To test how well the #BIMERVAX vaccine works, our partner research laboratories at <a href="/idibaps/">IDIBAPS</a> and <a href="/IrsiCaixa/">IrsiCaixa</a> have been assessing both the antibody and immune cell responses during the #RBDCOV trials. Have a look at our latest specialised article! 🔴👉shorturl.at/RninO